OverviewSuggest Edit

tella is a company that focuses on the research and development of regenerative and cellular medicine, including dendritic cell vaccine therapy. It is also engaged in the development of new cancer antigens, immunotherapies, and cell processing devices. In addition, the company provides medical institutions with technical and operational support for cell cultivation.
TypePublic
Founded2004
Websitetella.jp

Latest Updates

Employees (est.) (Apr 2020)35
Share Price (Jun 2020)¥1.5 K(-1%)
Cybersecurity ratingBMore

tella Financials and Metrics

tella Revenue

Market capitalization (25-Jun-2020)

31.7b

Closing stock price (25-Jun-2020)

1.5k
tella's current market capitalization is ¥31.7 b.
Show all financial metrics

tella Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

tella Online and Social Media Presence

Embed Graph

tella Frequently Asked Questions

  • When was tella founded?

    tella was founded in 2004.

  • How many employees does tella have?

    tella has 35 employees.

  • Who are tella competitors?

    Competitors of tella include Karo Pharma, MolMed and Immunovative Therapies.